Suchergebnisse - "Blum, Steven I"

PubPharm (51)

1

The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214

enthalten in: The oncologist | 2024

von Cella, D. | Choueiri, T. | Hamilton, M. | +5

2

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Moehler, M. | Xiao, H. | Blum, S. | +21

3

General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29

enthalten in: Cancer medicine | 2023

von Mohindra, N. | Peipert, J. | Blum, S. | +3

4

A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma

enthalten in: European urology oncology | 2023

von McGregor, B. | Geynisman, D. | Burotto, M. | +20

CommentIn: Eur Urol Oncol. 2023 Jun;6(3):349-350. - PMID 37032172

5

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer : CheckMate 9LA 2-year patient-reported outcomes

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Reck, M. | Ciuleanu, T. | Cobo, M. | +23

6

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Brahmer, J. | Lee, J. | Ciuleanu, T. | +21

CommentIn: J Clin Oncol. 2023 Feb 20;41(6):1172-1175. - PMID 36623229

7

General population reference values for the Functional Assessment of Cancer Therapy‐Lung and PROMIS‐29

enthalten in: Cancer Medicine | 2023

von Mohindra, N. | Peipert, J. | Blum, S. | +3

8

Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2022

von Eremenco, S. | Chen, W. | Blum, S. | +7

9

Three-year follow-up and patient-reported outcomes from CheckMate 078 : Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Chang, J. | Wu, Y. | Lu, S. | +26

10

Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER : an open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Cella, D. | Motzer, R. | Suarez, C. | +9

CommentIn: Lancet Oncol. 2022 May;23(5):e198. - PMID 35489342

1
2
3
4
5
6
Nächster »
[6]